Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes - A pilot study

Hijin You, Seung-Kyu Han, Jin Woo Lee, Hak Chang

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Diabetic foot ulcers often pose a difficult treatment problem. Repeated applications of cell-based products have been reported to result in acceleration of diabetic wound healing. The purpose of this clinical trial study was to report preliminary findings of the efficacy and safety of the cultured allogeneic keratinocyte sheets in the treatment of diabetic foot ulcers. Fifty-nine patients with diabetic foot ulcers were randomized to either the keratinocyte treatment group (n = 27) or the control group treated with vaseline gauze (n = 32). Except for the application of keratinocytes, treatment of study ulcers was identical for patients in both groups. Either keratinocyte sheet or vaseline gauze was applied at the beginning of the study and weekly thereafter for a maximum of 11 weeks. The maximum follow-up period for each patient was 12 weeks. Complete ulcer healing was achieved in 100% of the treatment group and 69% of the control group (p < 0.05). The Kaplan-Meier median times to complete closure were 35 and 57 days for the keratinocyte and control groups, respectively. No adverse events related to the treatment occurred. These results indicate that cultured allogeneic keratinocytes may offer a safe and effective treatment for diabetic foot ulcers.

Original languageEnglish
Pages (from-to)491-499
Number of pages9
JournalWound Repair and Regeneration
Volume20
Issue number4
DOIs
Publication statusPublished - 2012 Jul 1

Fingerprint

Diabetic Foot
Keratinocytes
Petrolatum
Control Groups
Therapeutics
Ulcer
Wound Healing
Clinical Trials
Safety

ASJC Scopus subject areas

  • Dermatology
  • Surgery

Cite this

Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes - A pilot study. / You, Hijin; Han, Seung-Kyu; Lee, Jin Woo; Chang, Hak.

In: Wound Repair and Regeneration, Vol. 20, No. 4, 01.07.2012, p. 491-499.

Research output: Contribution to journalArticle

@article{c448b888a47f4a9e83103c9c4eda20ef,
title = "Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes - A pilot study",
abstract = "Diabetic foot ulcers often pose a difficult treatment problem. Repeated applications of cell-based products have been reported to result in acceleration of diabetic wound healing. The purpose of this clinical trial study was to report preliminary findings of the efficacy and safety of the cultured allogeneic keratinocyte sheets in the treatment of diabetic foot ulcers. Fifty-nine patients with diabetic foot ulcers were randomized to either the keratinocyte treatment group (n = 27) or the control group treated with vaseline gauze (n = 32). Except for the application of keratinocytes, treatment of study ulcers was identical for patients in both groups. Either keratinocyte sheet or vaseline gauze was applied at the beginning of the study and weekly thereafter for a maximum of 11 weeks. The maximum follow-up period for each patient was 12 weeks. Complete ulcer healing was achieved in 100{\%} of the treatment group and 69{\%} of the control group (p < 0.05). The Kaplan-Meier median times to complete closure were 35 and 57 days for the keratinocyte and control groups, respectively. No adverse events related to the treatment occurred. These results indicate that cultured allogeneic keratinocytes may offer a safe and effective treatment for diabetic foot ulcers.",
author = "Hijin You and Seung-Kyu Han and Lee, {Jin Woo} and Hak Chang",
year = "2012",
month = "7",
day = "1",
doi = "10.1111/j.1524-475X.2012.00809.x",
language = "English",
volume = "20",
pages = "491--499",
journal = "Wound Repair and Regeneration",
issn = "1067-1927",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes - A pilot study

AU - You, Hijin

AU - Han, Seung-Kyu

AU - Lee, Jin Woo

AU - Chang, Hak

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Diabetic foot ulcers often pose a difficult treatment problem. Repeated applications of cell-based products have been reported to result in acceleration of diabetic wound healing. The purpose of this clinical trial study was to report preliminary findings of the efficacy and safety of the cultured allogeneic keratinocyte sheets in the treatment of diabetic foot ulcers. Fifty-nine patients with diabetic foot ulcers were randomized to either the keratinocyte treatment group (n = 27) or the control group treated with vaseline gauze (n = 32). Except for the application of keratinocytes, treatment of study ulcers was identical for patients in both groups. Either keratinocyte sheet or vaseline gauze was applied at the beginning of the study and weekly thereafter for a maximum of 11 weeks. The maximum follow-up period for each patient was 12 weeks. Complete ulcer healing was achieved in 100% of the treatment group and 69% of the control group (p < 0.05). The Kaplan-Meier median times to complete closure were 35 and 57 days for the keratinocyte and control groups, respectively. No adverse events related to the treatment occurred. These results indicate that cultured allogeneic keratinocytes may offer a safe and effective treatment for diabetic foot ulcers.

AB - Diabetic foot ulcers often pose a difficult treatment problem. Repeated applications of cell-based products have been reported to result in acceleration of diabetic wound healing. The purpose of this clinical trial study was to report preliminary findings of the efficacy and safety of the cultured allogeneic keratinocyte sheets in the treatment of diabetic foot ulcers. Fifty-nine patients with diabetic foot ulcers were randomized to either the keratinocyte treatment group (n = 27) or the control group treated with vaseline gauze (n = 32). Except for the application of keratinocytes, treatment of study ulcers was identical for patients in both groups. Either keratinocyte sheet or vaseline gauze was applied at the beginning of the study and weekly thereafter for a maximum of 11 weeks. The maximum follow-up period for each patient was 12 weeks. Complete ulcer healing was achieved in 100% of the treatment group and 69% of the control group (p < 0.05). The Kaplan-Meier median times to complete closure were 35 and 57 days for the keratinocyte and control groups, respectively. No adverse events related to the treatment occurred. These results indicate that cultured allogeneic keratinocytes may offer a safe and effective treatment for diabetic foot ulcers.

UR - http://www.scopus.com/inward/record.url?scp=84863498506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863498506&partnerID=8YFLogxK

U2 - 10.1111/j.1524-475X.2012.00809.x

DO - 10.1111/j.1524-475X.2012.00809.x

M3 - Article

C2 - 22672334

AN - SCOPUS:84863498506

VL - 20

SP - 491

EP - 499

JO - Wound Repair and Regeneration

JF - Wound Repair and Regeneration

SN - 1067-1927

IS - 4

ER -